My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

34.67 -0.13 (-0.37%)

Official Closing Price Updated: 5:00 PM EST, Dec 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

48 49 Next >

Why Hims & Hers Health (HIMS) Stock Is Nosediving

October 10, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.5% in the afternoon session after a Bank of America report highlighted weakening order trends and a lowered fourth-quarter revenue...

Via StockStory

Topics World Trade

Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office

October 09, 2025

From Hims & Hers

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

October 08, 2025

Via Benzinga

How Is The Market Feeling About Hims & Hers Health? ↗

September 18, 2025

Via Benzinga

HIMS & HERS HEALTH INC (NYSE:HIMS) Shows Strong Technical Setup Ahead of Potential Breakout ↗

October 07, 2025

HIMS stock shows strong technical momentum and a consolidation pattern, suggesting a potential breakout. The setup offers a clear risk/reward profile for technical traders.

Via Chartmill

10 Health Care Stocks Whale Activity In Today's Session ↗

October 06, 2025

Via Benzinga

Why Hims & Hers Stock Slipped Today ↗

October 03, 2025

Investors generally aren't fond of C-suite changes in relatively young businesses.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

October 03, 2025

Via Benzinga

HIMS & HERS HEALTH INC (NYSE:HIMS) Shows High-Growth Momentum and Technical Breakout Potential ↗

October 03, 2025

Hims & Hers (HIMS) is a high-growth momentum stock with strong earnings and a positive technical breakout setup, offering a compelling opportunity for investors.

Via Chartmill

agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know

October 02, 2025

A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations.

Via StockStory

Topics World Trade

Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment ↗

October 01, 2025

Via Benzinga

The Secret to Finding the Next Amazon Is Hiding in Plain Sight ↗

October 01, 2025

These innovators are disrupting massive industries with a customer-centric business strategy.

Via The Motley Fool

Topics Retirement

Eli Lilly Stock Jumps As Trump’s Drug Price Crackdown Spurs Sector Rally; Analysts Say Pfizer Deal Sets Template For Big Pharma ↗

September 30, 2025

Via Stocktwits

Topics Government

Six Stocks That Shocked Wall Street: Unpacking This Year's Surprise Market Winners

September 29, 2025

The year 2025 has unfolded with a compelling narrative of unexpected triumphs in the stock market, where several companies have defied conventional wisdom and analyst forecasts to emerge as significant...

Via MarketMinute

Topics Artificial Intelligence Economy

Not Nearly Enough People Are Talking About Chewy Stock ↗

September 28, 2025

The company has multiple trends working in its favor.

Via The Motley Fool

Topics Artificial Intelligence

3 Healthcare Stocks Using AI to Drive Growth ↗

September 27, 2025

AI is reshaping healthcare by improving outcomes and easing burnout. See how three companies are leading this transformation

Via MarketBeat

Topics Artificial Intelligence

Hims & Hers Powers YieldMax's Latest Options-Based Income ETF ↗

September 26, 2025

YieldMax ETFs grew its expanding lineup of income-oriented funds on Tuesday with the introduction of the YieldMax HIMS Option Income Strategy ETF (NYSE: HIYY).

Via Benzinga

Topics ETFs

A Healthcare Debate: Progyny vs. Hims & Hers ↗

September 26, 2025

Motley Fool analysts take a look.

Via The Motley Fool

1 Momentum Stock with Competitive Advantages and 2 We Find Risky

September 26, 2025

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or...

Via StockStory

2 Volatile Stocks Worth Investigating and 1 That Underwhelm

September 25, 2025

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced...

Via StockStory

I'm Downgrading Hims & Hers Stock ↗

September 24, 2025

The fast-growing company is taking investors on a roller-coaster ride.

Via The Motley Fool

Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today

September 23, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 2% in the morning session after an insider filed to sell a substantial block of shares.

Via StockStory

Nvidia Just Got Another Tailwind -- Why Groq's $6.9 Billion Valuation Proves AI Chips Are Still Hot ↗

September 23, 2025

Nvidia's unquestioned scale and ecosystem make it a clear winner.

Via The Motley Fool

Topics Artificial Intelligence Supply Chain

3 Big Short Interest Names with Bullish Setups ↗

September 22, 2025

HIMS, DLO, and TEM combine high short interest with bullish chart setups, creating strong breakout potential as market momentum stays hot.

Via MarketBeat

Topics Artificial Intelligence

Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy ↗

September 21, 2025

Hims & Hers Health posted 73% revenue growth and 31% more subscribers in Q2. With analyst targets hitting $68, is now the time to buy HIMS?

Via MarketBeat

Topics Economy

Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why

September 19, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 3.5% in the morning session after investors focused on the company's strong growth prospects, which appeared to overshadow recent...

Via StockStory

Oscar Health Set For HIMS-Style Moonshot? Shorts Could Burn As ACA Buzz Builds ↗

September 19, 2025

Oscar Health (OSCR) is drawing comparisons to Hims & Hers (HIMS) as short sellers may trigger a moonshot with ACA subsidies and a potential government shutdown.

Via Benzinga

The Weight-Loss Craze Boosted The $186 Billion Telehealth Industry. What It Means For Investors. ↗

September 19, 2025

Telehealth companies are getting a fresh infusion of business thanks to obesity drugs. Find out which stocks are benefiting.

Via Investor's Business Daily

Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs ↗

September 18, 2025

The FDA's warnings to Eli Lilly, Novo Nordisk and Hims & Hers spotlight risks for ETFs tied to the weight-loss drug boom.

Via Benzinga

Topics ETFs

Hims & Hers Health's Options Frenzy: What You Need to Know ↗

September 17, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

48 49 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.